The company has invested 2 million Euros in state-of-the-art technology with the aim to expand its R&D and Quality Control services addressed to the biopharmaceutical industry. The new headquarters takes up an area of 1,500 sq.m. at the Parc Tecnològic del Vallès (Barcelona). Kymos is going ahead with its internationalisation projects and expects a yearly growth of 20% for the following years.